Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme

The biology of recurrent glioblastoma multiforme (GBM) is a dynamic process influenced by selection pressure induced by different antitumoural therapies. The poor clinical outcome of tumours in the recurrent stage necessitates the development of effective therapeutic strategies. Checkpoint-inhibitio...

Descripción completa

Detalles Bibliográficos
Autores principales: Heynckes, Sabrina, Gaebelein, Annette, Haaker, Gerrit, Grauvogel, Jürgen, Franco, Pamela, Mader, Irina, Carro, Maria Stella, Prinz, Marco, Delev, Daniel, Schnell, Oliver, Heiland, Dieter Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650331/
https://www.ncbi.nlm.nih.gov/pubmed/29088776
http://dx.doi.org/10.18632/oncotarget.18819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650331/
https://www.ncbi.nlm.nih.gov/pubmed/29088776
http://dx.doi.org/10.18632/oncotarget.18819

Ejemplares similares